| Trial ID: | L0322 |
| Source ID: | NCT01305317
|
| Associated Drug: |
Lipitor
|
| Title: |
Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Lipitor
|
| Outcome Measures: |
Primary: Serum IgG, IgA and IgM level, 6 months | Secondary: Drug side effects, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Hormozgan University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
74
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2007-01
|
| Completion Date: |
2010-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-03-01
|
| Locations: |
Shahid Mohammadi hospital, Bandar Abbas, Hormozgan, 79176, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01305317
|
